Tricol Biomedical, Inc.

Tricol Biomedical, Inc. is a medical device company based in Portland, Oregon, specializing in advanced acute wound care and rapid hemorrhage control solutions. Founded in 2001, the company has established itself as a leader in hemostatic and wound care technologies, aiming to save and improve lives through innovative medical products. The company develops proprietary chitosan-based hemostatic products, including the HemCon PRO and Chito+ lines, which promote rapid blood clotting. Their product portfolio features HemCon Bandages for battlefield use, enhanced dressings for trauma management, and the OneStop product line for various medical needs. These products are utilized by healthcare professionals, military personnel, and consumers in diverse settings, from hospitals to homes. Tricol Biomedical emphasizes research and development, collaborating with organizations like the U.S. Army and receiving support from the National Institutes of Health. With a dedicated team and a commitment to advancing standards of care, Tricol Biomedical continues to make a significant impact in hemostatic and wound management globally.

• Employees 13
• Founded 2001
• Annual Revenue $4293000
• Total Funding $12000000